Atlas Trials

Role of Nefopam in Rituximab Transfusion Reaction

Clinical trial NCT05648058 · UNKNOWN

Trial details

NCT number
NCT05648058
Sponsor
Ministry Of Health / Nineveh Health Directorate
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nefopam
Start date
2022-12-20
Primary completion
2023-10-20
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.